tiprankstipranks
Integra Lifesciences Holdings Corp. (IART)
NASDAQ:IART
US Market

Integra Lifesciences (IART) Income Statement

Compare
240 Followers

Integra Lifesciences Income Statement

Last quarter (Q3 2024), Integra Lifesciences's total revenue was $380.83M, a decrease of -0.41% from the same quarter last year. In Q3, Integra Lifesciences's net income was $-10.70M. See Integra Lifesciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 1.54B$ 1.56B$ 1.54B$ 1.37B$ 1.52B
Gross Profit
$ 888.39M$ 970.31M$ 944.64M$ 851.03M$ 952.88M
Operating Expenses
$ 836.39M$ 731.39M$ 747.41M$ 699.66M$ 794.20M
Depreciation and Amortization
$ 123.51M$ 121.11M$ 123.67M$ 118.99M$ 114.70M
EBITDA
$ 274.01M$ 391.10M$ 366.33M$ 267.93M$ 231.03M
Operating Income
$ 111.53M$ 238.92M$ 197.23M$ 151.37M$ 178.98M
Other Income/Expenses
$ -30.46M$ -25.03M$ 17.45M$ -57.85M$ -33.66M
Pretax Income
$ 81.07M$ 213.89M$ 214.68M$ 93.52M$ 60.10M
Net Income
$ 67.74M$ 180.55M$ 169.07M$ 133.89M$ 50.20M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ 0.87$ 2.18$ 2.00$ 1.58$ 0.59
Diluted EPS
$ 0.84$ 2.16$ 1.98$ 1.57$ 0.58
Weighted Average Shares Outstanding
78.17M 83.00M 84.70M 84.65M 85.64M
Weighted Average Shares Outstanding (Diluted)
80.34M 83.52M 85.48M 85.23M 86.49M
Currency in USD

Integra Lifesciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis